Pancreatic islet and stellate cells are the main sources of endocrine gland-derived vascular endothelial growth factor/prokineticin-1 in pancreatic cancer

Pancreatology

Volumn 9, Issue 1-2, 2009, Pages 165-172

  Jiang, Xiaohua ^a,c   Abiatari, Ivane ^a   Kong, Bo ^a   Erkan, Mert ^a   De Oliveira, Tiago ^a   Giese, Nathalia A ^b   Michalski, Christoph W ^a   Friess, Helmut ^a   Kleeff, Jörg ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c SOUTHEAST UNIVERSITY   (China)

Author keywords

Endocrine gland derived vascular endothelial growth factor (EG VEGF); Pancreatic adenocarcinoma; Stellate cells

Indexed keywords

ENDOCRINE GLAND DERIVED VASCULAR ENDOTHELIAL GROWTH FACTOR; MESSENGER RNA; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CANCER CELL CULTURE; CHRONIC PANCREATITIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PANCREAS ADENOCARCINOMA; PANCREAS ISLET CELL; PRIORITY JOURNAL; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STELLATE CELL; TUMOR VASCULARIZATION;

EID: 57449083295     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1159/000178888     Document Type: Article

References (35)

1. Carmeliet P: Angiogenesis in life, disease and medicine. Nature 2005; 438: 932-936.
2. Bergers G, Benjamin LE: Tumorigenesis and the angiogenic switch. Nat Rev Cancer 2003; 3: 401-410.
3. Saif MW: Anti-angiogenesis therapy in pancreatic carcinoma. JOP 2006; 7: 163-173.
4. Abdollahi A, Schwager C, Kleeff J, Esposito I, Domhan S, Peschke P, Hauser K, Hahnfeldt P, Hlatky L, Debus J, Peters JM, Friess H, Folkman J, Huber PE: Transcriptional network governing the angiogenic switch in human pancreatic cancer. Proc Natl Acad Sci USA 2007; 104: 12890-12895.
5. Byrne AM, Bouchier-Hayes DJ, Harmey JH: Angiogenic and cell survival functions of vascular endothelial growth factor. J Cell Mol Med 2005; 9: 777-794.
6. Weis SM, Cheresh DA: Pathophysiological consequences of VEGF-induced vascular permeability. Nature 2005; 437: 497-504.
7. Ferrara N, Alitalo K: Clinical applications of angiogenic growth factors and their inhibitors. Nat Med 1999; 5: 1359-1364.
8. LeCouter J, Kowalski J, Foster J, Hass P, Zhang Z, Dillard-Telm L, Frantz G, Rangell L, DeGuzman L, Keller GA, Peale F, Gurney A, Hillan KJ, Ferrara N: Identification of an angiogenic mitogen selective for endocrine gland endothelium. Nature 2001; 412: 877- 884.
9. LeCouter J, Ferrara N: EG-VEGF and the concept of tissue-specific angiogenic growth factors. Semin Cell Dev Biol 2002; 13: 3-8.
10. Battersby S, Critchley HO, Morgan K, Millar RP, Jabbour HN: Expression and regulation of the prokineticins (endocrine gland-derived vascular endothelial growth factor and Bv8) and their receptors in the human endometrium across the menstrual cycle. J Clin Endocrinol Metab 2004; 89: 2463-2469.
11. Zhang L, Yang N, Conejo-Garcia JR, Katsaros D, Mohamed-Hadley A, Fracchioli S, Schlienger K, Toll A, Levine B, Rubin SC, Coukos G: Expression of endocrine glandderived vascular endothelial growth factor in ovarian carcinoma. Clin Cancer Res 2003; 9: 264-272.
12. Hoffmann P, Feige JJ, Alfaidy N: Expression and oxygen regulation of endocrine glandderived vascular endothelial growth factor/ prokineticin-1 and its receptors in human placenta during early pregnancy. Endocrinology 2006; 147: 1675-1684.
13. LeCouter J, Lin R, Tejada M, Frantz G, Peale F, Hillan KJ, Ferrara N: The endocrinegland- derived VEGF homologue Bv8 promotes angiogenesis in the testis: localization of Bv8 receptors to endothelial cells. Proc Natl Acad Sci USA 2003; 100: 2685-2690.
14. Lin DC, Bullock CM, Ehlert FJ, Chen JL, Tian H, Zhou QY: Identification and molecular characterization of two closely related G-protein-coupled receptors activated by prokineticins/endocrine gland vascular endothelial growth factor. J Biol Chem 2002; 277: 19276-19280.
15. Soga T, Matsumoto S, Oda T, Saito T, Hiyama H, Takasaki J, Kamohara M, Ohishi T, Matsushime H, Furuichi K: Molecular cloning and characterization of prokineticin receptors. Biochim Biophys Acta 2002; 1579: 173- 179.
16. Bachem MG, Schneider E, Gross H, Weidenbach H, Schmid RM, Menke A, Siech M, Beger H, Grunert A, Adler G: Identification, culture, and characterization of pancreatic stellate cells in rats and humans. Gastroenterology 1998; 115: 421-432.
17. Abiatari I, Kleeff J, Li J, Felix K, Büchler MW, Friess H: Hsulf-1 regulates growth and invasion of pancreatic cancer cells. J Clin Pathol 2006; 59: 1052-1058.
18. Welsch T, Kleeff J, Friess H: Molecular pathogenesis of pancreatic cancer: advances and challenges. Curr Mol Med 2007; 7: 504- 521.
19. Fernandez-Zapico ME, Kaczynski JA, Urrutia R: Pancreatic cancer research: challenges, opportunities, and recent developments. Curr Opin Gastroenterol 2002; 18: 563-567.
20. Talar-Wojnarowska R, Malecka-Panas E: Molecular pathogenesis of pancreatic adenocarcinoma: potential clinical implications. Med Sci Monit 2006; 12:RA186-RA193.
21. Bachem MG, Schunemann M, Ramadani M, Siech M, Beger H, Buck A, Zhou S, Schmid- Kotsas A, Adler G: Pancreatic carcinoma cells induce fibrosis by stimulating proliferation and matrix synthesis of stellate cells. Gastroenterology 2005; 128: 907-921.
22. Jaster R: Molecular regulation of pancreatic stellate cell function. Mol Cancer 2004; 3: 26.
23. Omary MB, Lugea A, Lowe AW, Pandol SJ: The pancreatic stellate cell: a star on the rise in pancreatic diseases. J Clin Invest 2007; 117: 50-59.
24. Greten FR, Wagner M, Weber CK, Zechner U, Adler G, Schmid RM: TGF- - transgenic mice. A model of pancreatic cancer development. Pancreatology 2001; 1: 363-368.
25. Schneiderhan W, Diaz F, Fundel M, Zhou S, Siech M, Hasel C, Moller P, Gschwend JE, Seufferlein T, Gress T, Adler G, Bachem MG: Pancreatic stellate cells are an important source of MMP-2 in human pancreatic cancer and accelerate tumor progression in a murine xenograft model and CAM assay. J Cell Sci 2007; 120: 512-519.
26. Erkan M, Kleeff J, Gorbachevski A, Reiser C, Mitkus T, Esposito I, Giese T, Büchler MW, Giese NA, Friess H: Periostin creates a tumor- supportive microenvironment in the pancreas by sustaining fibrogenic stellate cell activity. Gastroenterology 2007; 132: 1447-1464.
27. Neesse A, Wagner M, Ellenrieder V, Bachem M, Gress TM, Buchholz M: Pancreatic stellate cells potentiate proinvasive effects of SERPINE2 expression in pancreatic cancer xenograft tumors. Pancreatology 2007; 7: 380-385.
28. Zhang W, Erkan M, Abiatari I, Giese NA, Felix K, Kayed H, Büchler MW, Friess H, Kleeff J: Expression of extracellular matrix metalloproteinase inducer (EMMPRIN/CD147) in pancreatic neoplasm and pancreatic stellate cells. Cancer Biol Ther 2007; 6: 218-227.
29. Samson M, Peale FV Jr, Frantz G, Rioux- Leclercq N, Rajpert-De Meyts E, Ferrara N: Human endocrine gland-derived vascular endothelial growth factor: expression early in development and in Leydig cell tumors suggests roles in normal and pathological testis angiogenesis. J Clin Endocrinol Metab 2004; 89: 4078-4088.
30. Pasquali D, Rossi V, Staibano S, De Rosa G, Chieffi P, Prezioso D, Mirone V, Mascolo M, Tramontano D, Bellastella A, Sinisi AA: The endocrine-gland- derived vascular endothelial growth factor (EG-VEGF)/prokineticin1 and 2 and receptor expression in human prostate: up-regulation of EG-VEGF/prokineticin1 with malignancy. Endocrinology 2006; 147: 4245-4251.
31. Goi T, Fujioka M, Satoh Y, Tabata S, Koneri K, Nagano H, Hirono Y, Katayama K, Hirose K, Yamaguchi A: Angiogenesis and tumor proliferation/ metastasis of human colorectal cancer cell line SW620 transfected with endocrine glands-derived-vascular endothelial growth factor, as a new angiogenic factor. Cancer Res 2004; 64: 1906-1910.
32. Miyamoto H, Murakami T, Tsuchida K, Sugino H, Miyake H, Tashiro S: Tumor-stroma interaction of human pancreatic cancer: acquired resistance to anticancer drugs and proliferation regulation is dependent on extracellular matrix proteins. Pancreas 2004; 28: 38-44.
33. Zalatnai A: Molecular aspects of stromal-parenchymal interactions in malignant neoplasms. Curr Mol Med 2006; 6: 685-693.
34. Lecouter J, Lin R, Ferrara N: EG-VEGF: a novel mediator of endocrine-specific angiogenesis, endothelial phenotype, and function. Ann NY Acad Sci 2004; 1014: 50-57.
35. Lin R, LeCouter J, Kowalski J, Ferrara N: Characterization of endocrine gland-derived vascular endothelial growth factor signaling in adrenal cortex capillary endothelial cells. J Biol Chem 2002; 277: 8724-8729.